BioCryst Pharmaceuticals (BCRX) Short Interest Ratio & Short Volume $8.29 -0.92 (-9.99%) Closing price 02/24/2025 04:00 PM EasternExtended Trading$8.25 -0.04 (-0.48%) As of 02/24/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BioCryst Pharmaceuticals Short Interest DataBioCryst Pharmaceuticals (BCRX) has a short interest of 17.31 million shares. This marks a 1.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.1, indicating that it would take 8.1 days of the average trading volume of 3.00 million shares to cover all short positions.Current Short Interest17,310,000 sharesPrevious Short Interest17,010,000 sharesChange Vs. Previous Month+1.76%Dollar Volume Sold Short$136.75 millionShort Interest Ratio8.1 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares207,130,000 sharesPercentage of Shares Shorted8.36%Today's Trading Volume6,078,221 sharesAverage Trading Volume2,998,450 sharesToday's Volume Vs. Average203% Short Selling BioCryst Pharmaceuticals? Sign up to receive the latest short interest report for BioCryst Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCRX Short Interest Over TimeBCRX Days to Cover Over TimeBCRX Percentage of Float Shorted Over Time BioCryst Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202517,310,000 shares $136.75 million +1.8%N/A8.1 $7.90 1/15/202517,010,000 shares $122.98 million +8.2%N/A7.6 $7.23 12/31/202415,720,000 shares $118.21 million -9.1%N/A7.7 $7.52 12/15/202417,290,000 shares $130.19 million -10.7%N/A8.7 $7.53 11/30/202419,360,000 shares $145.20 million +4.7%N/A9.9 $7.50 11/15/202418,490,000 shares $129.98 million -11.2%N/A9.3 $7.03 10/31/202420,830,000 shares $166.85 million -7.6%N/A10.7 $8.01 10/15/202422,530,000 shares $168.52 million -3.0%N/A11.4 $7.48 9/30/202423,230,000 shares $176.55 million -4.5%N/A10.8 $7.60 9/15/202424,320,000 shares $192.61 million +1.1%N/A10.3 $7.92 Get the Latest News and Ratings for BCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCryst Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/202424,060,000 shares $209.08 million -3.0%N/A8.9 $8.69 8/15/202424,810,000 shares $189.30 million +1.8%N/A8.2 $7.63 7/31/202424,380,000 shares $177.49 million +11.8%N/A7.1 $7.28 7/15/202421,810,000 shares $156.60 million +22.0%N/A6 $7.18 6/30/202417,880,000 shares $110.50 million -39.7%N/A5 $6.18 6/15/202429,670,000 shares $183.06 million -18.0%N/A8.1 $6.17 5/31/202436,180,000 shares $233.72 million +5.3%N/A9.9 $6.46 5/15/202434,350,000 shares $218.47 million +2.1%N/A9.5 $6.36 4/30/202433,640,000 shares $138.93 million -2.2%N/A9.9 $4.13 4/15/202434,390,000 shares $160.60 million +6.6%N/A11 $4.67 3/31/202432,250,000 shares $163.83 million +5.6%N/A9.8 $5.08 3/15/202430,550,000 shares $152.75 million +5.0%N/A9.3 $5.00 2/29/202429,100,000 shares $163.83 million -1.1%N/A7.4 $5.63 2/15/202429,410,000 shares $165.87 million +1.3%N/A7.6 $5.64 1/31/202429,040,000 shares $153.91 million +3.5%N/A7.6 $5.30 1/15/202428,050,000 shares $178.12 million -6.8%N/A7.1 $6.35 12/31/202330,080,000 shares $180.18 million +1.0%N/A7.4 $5.99 12/15/202329,780,000 shares $184.34 million +1.4%N/A7.8 $6.19 11/30/202329,380,000 shares $172.75 million -0.3%N/A8.5 $5.88 11/15/202329,470,000 shares $153.54 million -2.2%N/A10.3 $5.21 10/31/202330,130,000 shares $165.41 million -31.8%N/A10.9 $5.49 10/15/202344,190,000 shares $262.49 million +4.3%N/A15.5 $5.94 9/30/202342,390,000 shares $300.12 million -0.3%N/A17 $7.08 9/15/202342,500,000 shares $291.13 million +2.9%N/A16.9 $6.85 8/31/202341,300,000 shares $293.64 million +3.1%N/A16.3 $7.11 8/15/202340,060,000 shares $278.02 million +2.7%N/A15.2 $6.94 7/31/202339,000,000 shares $288.21 million +3.4%N/A14.7 $7.39 7/15/202337,730,000 shares $269.01 million +0.9%N/A14.9 $7.13 6/30/202337,390,000 shares $263.23 million +5.4%N/A13.8 $7.04 6/15/202335,480,000 shares $283.13 million -0.3%N/A12.9 $7.98Grab This Altcoin Before Trump's Crypto Announcement (Ad)Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now 5/31/202335,580,000 shares $294.25 million +10.2%N/A13 $8.27 5/15/202332,300,000 shares $283.27 million +3.5%N/A11 $8.77 4/30/202331,200,000 shares $237.43 million +2.8%N/A10.2 $7.61 4/15/202330,360,000 shares $245.01 million -2.8%N/A10.5 $8.07 3/31/202331,220,000 shares $260.37 million +1.3%N/A10.7 $8.34 3/15/202330,810,000 shares $257.88 million +4.5%N/A10.3 $8.37 2/28/202329,480,000 shares $260.90 million +9.2%N/A9.9 $8.85 2/15/202326,990,000 shares $274.22 million +1.2%N/A9.7 $10.16 1/31/202326,680,000 shares $281.47 million +2.2%N/A10.2 $10.55 1/15/202326,110,000 shares $265.28 million -4.2%N/A8.8 $10.16 12/30/202227,240,000 shares $312.72 million -1.6%N/A9.6 $11.48 12/15/202227,680,000 shares $299.22 million +0.3%N/A10.3 $10.81 11/30/202227,610,000 shares $368.87 million -0.9%N/A10.3 $13.36 11/15/202227,870,000 shares $369.00 million +0.9%N/A10.7 $13.24 10/31/202227,630,000 shares $368.86 million -2.3%N/A10.5 $13.35 10/15/202228,290,000 shares $382.76 million +0.6%N/A11 $13.53 9/30/202228,130,000 shares $354.44 million -2.4%N/A10.9 $12.60 9/15/202228,820,000 shares $369.76 million +3.3%N/A10.5 $12.83 8/31/202227,910,000 shares $387.95 million +2.1%N/A9.7 $13.90 8/15/202227,350,000 shares $405.05 million -7.9%N/A9.1 $14.81 7/31/202229,680,000 shares $327.07 million -5.7%N/A8.7 $11.02 7/15/202231,460,000 shares $366.51 million +0.5%N/A8.5 $11.65 6/30/202231,300,000 shares $331.15 million +5.4%N/A6.4 $10.58 6/15/202229,690,000 shares $276.12 million +0.5%N/A6.2 $9.30 5/31/202229,550,000 shares $275.11 million -0.3%N/A6.3 $9.31 5/15/202229,650,000 shares $248.76 million -3.4%N/A6.1 $8.39 4/30/202230,690,000 shares $285.11 million +7.5%N/A6.4 $9.29 4/15/202228,550,000 shares $325.18 million +11.7%N/A6.5 $11.39 3/31/202225,570,000 shares $415.77 million -5.4%N/A5.6 $16.26 3/15/202227,030,000 shares $409.77 million +2.0%N/A6.9 $15.16 2/28/202226,500,000 shares $440.17 million +2.6%N/A7 $16.61 2/15/202225,820,000 shares $484.38 million +3.2%14.7%6.9 $18.76 1/31/202225,020,000 shares $386.56 million -1.8%14.1%7.1 $15.45 1/15/202225,470,000 shares $394.28 million -2.3%14.4%7 $15.48 12/31/202126,080,000 shares $361.21 million +6.3%14.8%8 $13.85 12/15/202124,540,000 shares $291.29 million +1.5%14.0%8.7 $11.87 11/30/202124,180,000 shares $291.61 million +7.2%13.7%8.9 $12.06 11/15/202122,550,000 shares $267.67 million +10.4%12.7%8.6 $11.87 10/29/202120,420,000 shares $304.87 million +7.6%11.5%7.4 $14.93 10/15/202118,970,000 shares $287.02 million +2.3%10.7%7.2 $15.13 9/30/202118,540,000 shares $266.42 million -2.3%10.5%6.9 $14.37 9/15/202118,980,000 shares $286.03 million -1.6%10.7%6.8 $15.07 8/31/202119,290,000 shares $307.10 million -6.1%10.9%6.5 $15.92 8/13/202120,540,000 shares $331.72 million +11.9%11.6%6.4 $16.15 7/30/202118,350,000 shares $295.80 million -0.1%10.5%5.4 $16.12 7/15/202118,370,000 shares $290.25 million -4.1%10.5%5.3 $15.80 6/30/202119,150,000 shares $302.76 million -2.0%10.9%5.2 $15.81 6/15/202119,530,000 shares $304.86 million -2.4%11.1%5.1 $15.61 5/28/202120,010,000 shares $315.56 million -9.6%11.4%4.3 $15.77 5/14/202122,130,000 shares $264.67 million -3.6%N/A4.3 $11.96Shocking Elon Move: Bigger than DOGE? (Ad)After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recent DOGE moves… What Elon Musk is about to do next could not only shock the world… But also put an extra $30,000 a year in your pocket.Click here to see the details BEFORE March 17th… 4/30/202122,950,000 shares $278.15 million -8.1%N/A4.1 $12.12 4/15/202124,980,000 shares $254.55 million +7.0%N/A3.7 $10.19 3/31/202123,350,000 shares $233.27 million -12.5%N/A3.3 $9.99 3/15/202126,680,000 shares $337.24 million -7.8%N/A3.5 $12.64 2/26/202128,920,000 shares $302.79 million +0.2%N/A3.5 $10.47 2/12/202128,860,000 shares $265.51 million -8.5%N/A3.5 $9.20 1/29/202131,530,000 shares $274.63 million +1.9%N/A4 $8.71 1/15/202130,950,000 shares $265.86 million No ChangeN/A4.6 $8.59 12/31/202030,950,000 shares $232.13 million -16.4%N/A4.7 $7.50 12/15/202037,040,000 shares $314.84 million -1.0%N/A5.5 $8.50 11/30/202037,420,000 shares $191.96 million -1.7%N/A6.2 $5.13 11/15/202038,070,000 shares $167.89 million -7.9%N/A7.6 $4.41 10/30/202041,320,000 shares $154.12 million +8.5%N/A8.1 $3.73 10/15/202038,100,000 shares $147.83 million +4.7%N/A6.8 $3.88 9/30/202036,390,000 shares $125.00 million +5.0%N/A6.2 $3.44 9/15/202034,650,000 shares $138.60 million +3.3%N/A5.3 $4.00 8/31/202033,560,000 shares $139.27 million -11.7%N/A4.8 $4.15 8/14/202038,010,000 shares $163.44 million +11.8%N/A5.2 $4.30 7/31/202034,000,000 shares $138.38 million +9.3%N/A4.1 $4.07 7/15/202031,100,000 shares $162.50 million -3.1%N/A3.2 $5.23 6/30/202032,100,000 shares $152.96 million +55.6%N/A2.9 $4.77 6/15/202020,630,000 shares $92.63 million +11.9%N/A2 $4.49 5/29/202018,430,000 shares $82.75 million +8.0%N/A1.7 $4.49 5/15/202017,070,000 shares $90.30 million -4.6%N/A1.6 $5.29 4/30/202017,890,000 shares $69.95 million +1.5%N/A1.9 $3.91 4/15/202017,630,000 shares $47.60 million +11.2%N/A2.3 $2.70 3/31/202015,860,000 shares $56.46 million -1.2%N/A2.8 $3.56 3/13/202016,053,900 shares $33.23 million +7.5%N/A1.6 $2.07 2/28/202014,940,000 shares $29.28 million -2.3%N/A3.3 $1.96 BCRX Short Interest - Frequently Asked Questions What is BioCryst Pharmaceuticals' current short interest? Short interest is the volume of BioCryst Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 17,310,000 shares of BCRX short. Learn More on BioCryst Pharmaceuticals' current short interest. What is a good short interest ratio for BioCryst Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCRX shares currently have a short interest ratio of 8.0. Learn More on BioCryst Pharmaceuticals's short interest ratio. Which institutional investors are shorting BioCryst Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioCryst Pharmaceuticals: Wolverine Trading LLC, Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Capital LLC, and Barclays PLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BioCryst Pharmaceuticals' short interest increasing or decreasing? BioCryst Pharmaceuticals saw a increase in short interest in January. As of January 31st, there was short interest totaling 17,310,000 shares, an increase of 1.8% from the previous total of 17,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioCryst Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biotechnology" compare to BioCryst Pharmaceuticals: Halozyme Therapeutics, Inc. (7.22%), Madrigal Pharmaceuticals, Inc. (18.25%), Alkermes plc (6.83%), Ionis Pharmaceuticals, Inc. (7.87%), Amicus Therapeutics, Inc. (5.64%), Ligand Pharmaceuticals Incorporated (5.04%), Dynavax Technologies Co. (14.79%), Geron Co. (12.34%), Celldex Therapeutics, Inc. (13.37%), MannKind Co. (10.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short BioCryst Pharmaceuticals stock? Short selling BCRX is an investing strategy that aims to generate trading profit from BioCryst Pharmaceuticals as its price is falling. BCRX shares are trading down $0.92 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioCryst Pharmaceuticals? A short squeeze for BioCryst Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCRX, which in turn drives the price of the stock up even further. How often is BioCryst Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCRX, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies HALO Short Interest MDGL Short Interest ALKS Short Interest IONS Short Interest FOLD Short Interest LGND Short Interest DVAX Short Interest GERN Short Interest CLDX Short Interest MNKD Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCRX) was last updated on 2/25/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCryst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCryst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCRX Stock Alerts